Targretin

*** Please note that this product can only be paid for by bank transfer. To proceed, click the Contact Us For Availability link below and send us a message with your name, shipping address, and the quantity you wish to purchase. ***

Uses
Targretin (Bexarotene) is a retinoid prescribed to patients who suffer from a specific kind of skin cancer called cutaneous T-cell lymphoma, or abbreviated as CTCL. It is if proven to have significant benefits to patients due to its ability to inhibit the growth of cancer cells. Usually this medication is prescribed to patients who have already tried other treatments options unsuccessfully.

There is a growing body of evidence suggesting that Bexarotene has the ability to effectively reduce the severity of Alzheimer`s disease, a heartbreaking condition which is notoriously difficult to treat effectively. In recent months this medication has gained much media attention from various prestigious newspapers in reference to this off-label usage. Here is a Wall Street Journal article about Targretin (Bexarotene).

Dosage and Administration
Targretin (Bexarotene) is usually taken once per day, although correct dosage can only be determined by your doctor and can vary from patient to patient. Capsules should be swallowed whole and taken alongside a meal. Never stop taking this medication before the end of your prescribed treatment period without consulting your doctor beforehand. The effects may not be noticeable for several weeks or even months, so it is important to stick to your prescription and always go to your doctor to discuss any doubts you might have.

Side effects
There is always a risk of side effects when taking any medication, and Targretin (Bexarotene) is no different. The following side effects are unlikely, but have been previously reported by patients taking this medication.

• Nausea
• Vomiting
• Fatigue
• Fever
• Headaches
• Insomnia
• Dry skin
• Jaundice
• Darkened urine
• Vision changes

Precautions
Targretin (Bexarotene) has the potential to cause serious birth defects and should never be consumed by female patients who are pregnant, trying to conceive, or breastfeeding. Female patients require a pregnancy test at least one month before starting treatment with this medication, regularly throughout the treatment, and then one month after ceasing treatment. Over the period of treatment, and for one month afterwards, both male and female patients are strongly advised to use two types of contraceptive including one which is a non-hormonal barrier-method.

Targretin (Bexarotene) has been known to cause high cholesterol and hypothyroidism. Patients should attend regular blood tests while taking this medication. If you keep all appointments and attend all tests, these two adverse effects can be picked up early on.

Do not consume grapefruit or any products containing grapefruit (for example grapefruit juice) while taking this medication.